However, next-generation sequencing of tumour material have indeed revealed that TDs, in the same size-range as we have described here (~10 kb)46, are very frequent in genomes of BRCA1-deficient tumour cells but not in tumours associated with BRCA2 loss5,13,46,47. The gene discussed is BRCA1; the disease is neoplasm.